Purdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its ...

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...

Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic ...

Approval would take at least several more months. A previous version had bankruptcy court approval but was rejected last year ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

The plan put forth Tuesday could see the Sackler family pay up to $7 billion. Also in the news: Merck prepares to close its manufacturing plant in Pennsylvania; Optum Rx, which includes UnitedHealth ...

U.S. states claimed they are owed US$ 2.2 trillion ... backed by the wealthy Sackler family, contributed to a public health crisis that has claimed the lives of roughly 450,000 people since ...

NEW YORK, Feb 25 (Reuters) - Purdue Pharma told a U.S. bankruptcy judge on Tuesday that it will finalize a new bankruptcy plan in March, with the company's Sackler family owners potentially paying ...

Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

The US saw nearly half a million deaths from overdoses ... Meanwhile, some members of the Sackler family have previously agreed to pay $225 million to resolve civil allegations brought by the ...

just seven months after the U.S. Supreme Court struck down a previous settlement deal. If approved, Purdue Pharma will contribute $900 million upfront while the Sackler family pays $6.5 billion ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.